UBS Lux Equity Fund Biotech USD vs Heimdal Utbytte

UBS Lux Equity Fund Biotech USD vs Heimdal Utbytte

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Heimdal Utbytte

  • Security

    Heimdal Utbytte N

  • Fee

    1.29%

  • ISIN

    NO0012948852

  • Holdings

    25

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Heimdal Utbytte, we have 29 holdings where Sparebanken Vest is the largest holding (5.05), followed by Kongsberg (4.8) and DNB (4.8).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Heimdal Utbytte.

UBS Lux Equity Fund Biotech USD Heimdal Utbytte
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Sparebanken Vest
Norway
5.05 %
2. Moderna Inc
9.21 %
2. Kongsberg Gruppen ASA
Norway
4.8 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. DNB Bank
Norway
4.8 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. SpareBank 1 SMN
Norway
4.78 %
5. AbbVie Inc
USA
4.91 %
5. SpareBank 1 Sør-Norge ASA
Norway
4.75 %
6. Gilead Sciences Inc
USA
4.66 %
6. Protector Forsikring ASA
Norway
4.63 %
7. Amgen Inc
USA
4.43 %
7. Storebrand
Norway
4.59 %
8. BioNTech SE
4.13 %
8. Equinor ASA
Norway
4.57 %
9. Karuna Therapeutics Inc
3.75 %
9. Aker BP
Norway
4.48 %
- 10. Gjensidige Forsikring
Norway
4.44 %
- 11. Orkla Foods AS
Norway
4.41 %
- 12. SpareBank 1 Nord-Norge
Norway
4.22 %
- 13. Mowi
Norway
3.64 %
- 14. Telenor ASA
Norway
3.29 %
- 15. Schibsted A
Norway
3.26 %
- 16. Norconsult ASA
Norway
2.67 %
- 17. Pareto Bank ASA
Norway
2.05 %
- 18. Subsea 7 SA
Norway
1.99 %
- 19. SalMar ASA
Norway
1.74 %
- 20. Atea
1.67 %
- 21. Essity B
Sweden
1.54 %
- 22. Multiconsult ASA
Norway
1.41 %
- 23. Securitas B
Sweden
1.3 %
- 24. Borregaard ASA
Norway
1.29 %
- 25. BW Offshore Ltd
1.28 %

The list of fund holdings was last updated on July 25, 2025.